Artivion | CRY - 税前利润

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 873.6M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	税前利润	更改		日
Abbott	USD 2.39B		27M	2026-03
Accuray	USD 3.23M		6.56M	2024-12
AngioDynamics	USD -6.4M		5.03M	2025-09
Artivion	USD 11.4M		7.84M	2025-12
AtriCure	USD 394K		1.97M	2026-03
Baxter International	USD -756M		877M	2025-12
Becton, Dickinson and Co.	USD 393M		117M	2025-12
Boston Scientific	USD 700M		238M	2025-12
Edwards Lifesciences	USD 348.4M		51.8M	2025-09
Inogen	USD -6.06M		467K	2024-09
Integra LifeSciences	USD -2.41M		6.72M	2026-03
J&J	USD 7.82B		2.86B	2026-03
Mesa Laboratories	USD -2.22M		6.03M	2024-12
Orthofix International	USD -2.19M		20.07M	2025-12
Pfizer	USD 5.18B		6.82B	2026-03
ResMed	USD 496.15M		13.77M	2025-12
Stryker	USD 1.7B		676M	2025-12
Tandem Diabetes Care	USD 4.68M		29.82M	2025-12
Teleflex	USD 218.94M		657.52M	2025-12
Terumo	JPY 31.67B		13.71B	2026-03
Trinity Biotech	USD -5.06M		10.74M	2025-09